Publication: Evolving impact of long-term survival results on metastatic melanoma treatment
Evolving impact of long-term survival results on metastatic melanoma treatment
Date
Date
Date
Citations
Michielin, O., Atkins, M. B., Koon, H. B., Dummer, R., & Ascierto, P. A. (2020). Evolving impact of long-term survival results on metastatic melanoma treatment. Journal for ImmunoTherapy of Cancer, 8(2), e000948. https://doi.org/10.1136/jitc-2020-000948
Abstract
Abstract
Abstract
Melanoma treatment has been revolutionized over the past decade. Long-term results with immuno-oncology (I-O) agents and targeted therapies are providing evidence of durable survival for a substantial number of patients. These results have prompted consideration of how best to define long-term benefit and cure. Now more than ever, oncologists should be aware of the long-term outcomes demonstrated with these newer agents and their relevance to treatment decision-making. As the first tumor type for which I-O agents were approved, melano
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
- Michielin, Olivier
- Atkins, Michael B
- Koon, Henry B
- Dummer, Reinhard
- Ascierto, Paolo Antonio
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Keywords
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Downloads
Views
Citations
Michielin, O., Atkins, M. B., Koon, H. B., Dummer, R., & Ascierto, P. A. (2020). Evolving impact of long-term survival results on metastatic melanoma treatment. Journal for ImmunoTherapy of Cancer, 8(2), e000948. https://doi.org/10.1136/jitc-2020-000948
